Graves\' Disease Exacerbation with Impending Thyroid Storm After SARS-CoV-2 Infection: A Case Report
Authors:
Open Access
- 7 December 2023
- journal article
- research article
- Published by International Scientific Information, Inc. in American Journal of Case Reports
- Vol. 25, e941311-e941311-4
Abstract
BACKGROUND Since the COVID-19 pandemic, several cases of COVID-19 have been linked to the development of autoimmune disorders, including of the thyroid. Graves' disease (GD) is a rare complication that can occur following SARS-CoV-2 infection. Reports have linked COVID-19 to new onset and exacerbation of GD. We present a case of a 42-year-old woman with a history of GD presenting with impending thyroid storm 3 weeks following a diagnosis of COVID-19. CASE REPORT A 42-year-old woman with a history of GD presented to the Emergency Department (ED) for an acute exacerbation of hyperthyroidism 3 weeks after SARS-CoV-2 infection was diagnosed on a home test. Symptoms included daily headaches, increased bilateral eye pressure, fatigue, muscle weakness, episodes of confusion and agitation, persistent heart palpitations, and goiter. Elevated free T4 of 5.57, free T3 of 15.68, total T3 of 4.43, and near-absent thyroid stimulating hormone were noted. The Burch-Wartofsky scale was 40, which was concerning for an impending thyroid storm; however, at the time of admission, she was not in a thyroid storm. Treatment included propylthiouracil, potassium iodide oral solution, and propranolol, with symptom improvement. Due to prior history of intolerance to antithyroid medications and recent exacerbation, a thyroidectomy was performed once she was in a euthyroid state. CONCLUSIONS Our case demonstrates the importance of recognizing COVID-19 as an etiology or a trigger for new onset or exacerbation of GD. Our case highlights that being vigilant to recognize the association between COVID-19 and thyroid abnormalities for early diagnosis and treatment is imperative.Keywords
This publication has 20 references indexed in Scilit:
- Thyroid disease and hypothyroidism are associated with poor COVID-19 outcomes: A systematic review, meta-analysis, and meta-regressionDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- Case series: Rare cases of thyroid storm in COVID‐19 patientsClinical Case Reports, 2021
- Rheumatological complications of Covid 19Autoimmunity Reviews, 2021
- COVID-19 Associated Thyroid Storm: A Case ReportClinical Practice and Cases in Emergency Medicine, 2021
- Modulation of ACE-2 mRNA by inflammatory cytokines in human thyroid cells: a pilot studyEndocrine, 2021
- Coronavirus Disease 2019 and the Thyroid - Progress and PerspectivesFrontiers in Endocrinology, 2021
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 InfectionPathogens, 2021
- Thyroid Function Analysis in 50 Patients with COVID-19: A Retrospective StudyThyroid®, 2021
- The association between COVID-19 and type 1 diabetes mellitus: A systematic reviewDiabetes & Metabolic Syndrome: Clinical Research & Reviews, 2021
- Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissuesInfectious Diseases of Poverty, 2020